Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1987-12-01
1988-12-06
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 87, 424 93, A61K 3902, A61K 3910, A61K 39108, A61K 39104
Patent
active
047895446
ABSTRACT:
A composition for co-injection of an animal against a gram-negative pathogen which comprises an effective dose of a gram-negative type lipopolysaccharide devoid of O-carbohydrate side-chains and a bacterin derived from said pathogen. Methods of co-injection of an animal to protect the animal against gram-negative pathogens are also discussed.
REFERENCES:
patent: 3148120 (1964-09-01), Westphal
patent: 3185624 (1965-05-01), Nakazawa
patent: 3401219 (1968-09-01), Zeissig
patent: 3438862 (1969-04-01), Work
patent: 4016253 (1977-04-01), Switzer et al.
patent: 4167560 (1979-09-01), Wohler, Jr.
patent: 4428931 (1984-01-01), Tolman et al.
patent: 4455142 (1984-06-01), Martins et al.
patent: 4469672 (1984-09-01), Harris
patent: 4626430 (1986-12-01), Kucera
patent: 4663160 (1987-05-01), Tsay et al.
patent: 4687738 (1987-08-01), Ginnaga et al.
M. I. Marks, et al., Biological Abstracts, No. 39459, vol. 74, 1982.
J. D. Baumgartner, et al., Prevention of Gram-Negative Shock and Death in Surgical Patients by Antibody to Endotoxin Core Glycolipid, The Lancet, pp. 59-63, Jul. 13, 1985.
L. M. Mutharia, et al., Monoclonal Antibodies Specific for Escherichia coli J5 Lipopolysaccharide: Cross-Reaction with Other Gram-Negative Bacterial Species, Infection and Immunity, Sep. 1984, pp. 631-636, vol. 45, No. 3.
M. J. Nelles, et al., Mouse Monoclonal Antibodies Reactive with J5 Lipopolysaccharide Exhibit Extensive Serological Cross-Reactivity with a Variety of Gram-Negative Bacteria, Infection and Immunity, Dec. 1984, pp. 677-681, vol. 46, No. 3.
B. W. Fenwick, et al., Biological Abstracts, vol. 82, 1986, No. 82938.
D. Martinez, et al., Prophylaxis of Pseudomonas aeruginosa Infections in Leukopenic Mice by a Combination of Active and Passive Immunization, Eur. J. Clin. Microbiology, Apr. 1985, pp. 186-189, vol. 4, No. 2.
A. I. Braude, et al., Immunization Against Nosocomial Infection, The Amer. J. of Med., vol. 70, pp. 463-466, Feb. 1981.
D. L. Dunn, et al., Immunotherapy of Gram-Negative Bacterial Sepsis: Enhanced Survival in a Guinea Pig Model by use of rabbit Antiserum to Escherichia coli J5, Surgery, vol. 92, No. 2, pp. 212-219.
C. Galanos, et al., Preparation and Properties of Antisera against the Lipid-A Component of Bacterial Lipopolysaccharides, Eur. J. Biochem, vol. 24, pp. 116-122, 1971.
L. B. Corbeil, et al., Immunity to Pasteurellosis in Compromised Rabbits, Am. J. Vet. Res., vol. 44, No. 5, pp. 845-850.
A. I. Braude, et al., Antibody to Cell Wall Glycolipid of Gram-Negative Bacteria: Induction of Immunity to Bacteremia and Endotoxemia, The Jour. Inf. Dis., vol. 156, Supplement, Aug. 1977.
M. I. Marks, et al., Induction of Immunity Against Lethal Haemophilus influenzae Type b Infection by Escherichia coli Core Lipopolysaccharide, J. Clin. Invest., vol. 69, Apr. 1982, pp. 742-749.
A. I. Braude, et al., Protection against Gram-Negative Bacteremia with Antiserum to Endotoxins, Antiserum to LPS of Gram-Negative Bacteria, pp. 111-125.
Nelson Ralph
Schlink Gerald
Midcon Labs. Inc.
Schain Howard E.
LandOfFree
Co-vaccination using non-O-carbohydrate side-chain gram-negative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Co-vaccination using non-O-carbohydrate side-chain gram-negative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Co-vaccination using non-O-carbohydrate side-chain gram-negative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1493278